News
Hosted on MSN26d
Eli Lilly developing first oral weight loss drugMatlock,' 'Tracker' Reign as Canceled Shows Fall off the Map Drug manufacturer Eli Lilly's weight loss pill has completed late-stage trials for people with type 2 diabetes. The pill could offer an ...
Eli Lilly says it could pull tens of millions of ... We evaluate different markets and quite frankly, Australia is not on the map right now. It is up to Australia if it wants to compete in this ...
The Nasdaq Composite (^IXIC) holds onto Thursday gains to close over 1.5% higher, while the Dow Jones Industrial Average's ...
STORY: Stocks fell for the second straight session on Tuesday with the Dow ending about one percent lower, while the S&P 500 ...
Gastric cancer remains a major health challenge worldwide, with nearly 1 million new cases annually contributing to more than ...
9don MSNOpinion
Americans already pay far too much for prescription medications. Trump’s planned pharma tariffs will cause drug prices to ...
Work has begun in the UK on developing new tests that will spot if someone has “fat genes”. The project, which seeks to create simple blood or saliva tests, is being undertaken by a team at Oxford ...
A massive blackout affecting Spain, Portugal, and parts of France has been blamed on atmospheric conditions. Now engineers ...
Aer Lingus, the flagship carrier of Ireland, launched a nonstop route from Indianapolis to Dublin and back on May 3, restoring transatlantic service.
The stock (HIMS) soared 24.2% in midday trading toward a one-month closing high. It's on track the biggest one-day gain since it ran up 27.7% on Feb. 13, 2025. That rally was part of a big surge to ...
Topical BRAF inhibitor LUT014 gel significantly reduces acneiform rash from anti-EGFR therapies in patients with colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results